These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6275996)

  • 21. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH; Jones RN; Malledant J; Privitera G
    J Chemother; 1997 May; 9 Suppl 2():19-33. PubMed ID: 9248973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Initial clinical use of rifomycin in obstetrics and gynecology].
    Moggian G; Tamburini E
    G Clin Med; 1969 Oct; 50(10):916-64. PubMed ID: 5386617
    [No Abstract]   [Full Text] [Related]  

  • 23. Cefotaxime treatment of skin and skin structure infections: a multicenter study.
    LeFrock JL; McCloskey RV
    Clin Ther; 1982; 5 Suppl A():19-25. PubMed ID: 6293714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotaxime: microbiology, pharmacology, and clinical use.
    Dudley MN; Barriere SL
    Clin Pharm; 1982; 1(2):114-24. PubMed ID: 6309465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nonprophylactic role of cephalosporins in obstetrics and gynecology.
    LeFrock JL; Smith BR; Molavi A
    Bull N Y Acad Med; 1984 May; 60(4):416-25. PubMed ID: 6372917
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observations on the use of gentamicin in gynecology and obstetrics].
    Pescetto G; Baratta A; Menozzi MG
    G Ital Chemioter; 1969; 16(1):223-32. PubMed ID: 5404102
    [No Abstract]   [Full Text] [Related]  

  • 27. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the transplacental passage of cefotaxime in late pregnancy].
    Fujimoto S; Kanagawa Y
    Jpn J Antibiot; 1982 Jul; 35(7):1849-54. PubMed ID: 6294365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diffusion of cefotaxime in different tissues of the urogenital tract (author's transl)].
    Schalhäuser K; Adam D
    Infection; 1980; 8 Suppl 3():S 327-9. PubMed ID: 6250982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory and clinical studies on cefotaxime in obstetrics and gynecology (author's transl)].
    Miyamoto N; Nakamura H; Hayashi S
    Jpn J Antibiot; 1981 Apr; 34(4):495-99. PubMed ID: 6270397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions.
    Goodpasture HC; Gerlach EH; Jones RN; Peterie JD
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):97-103. PubMed ID: 3383550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transfer of cefotaxime to the pelvic organs (author's transl)].
    Ikeuchi M; Takashima E; Asano S; Haruta T; Morikawa Y; Kobayashi Y
    Jpn J Antibiot; 1981 Apr; 34(4):532-6. PubMed ID: 6270402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaerobic infections in obstetrics and gynecology.
    Jesurun HM; Held B
    Tex Med; 1975 Jul; 71(7):66-71. PubMed ID: 1154297
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vibravenös in gynecology and obstetrics].
    Varga L; Frischkopf H
    Gynakol Rundsch; 1974; 14(4):325-6. PubMed ID: 4474975
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotherapy by Magnipen in gynecology-obstetrics. Apropos of 50 cases].
    Leroy JL; Potier A; Delecour M
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1326-30. PubMed ID: 4802851
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of doxycycline in gynecology and obstetrics].
    Chaabouni M; Chaabouni Z
    Tunis Med; 1971; 3():161-3. PubMed ID: 5140382
    [No Abstract]   [Full Text] [Related]  

  • 38. In the general gynecological literature, communications about infections in obstetrics and gynecology are certainly not in proportion with the frequency and severity of the pathology as we encounter it every day in our clinical practice.
    Donders GG
    Gynecol Obstet Invest; 2010; 70(4):221-3. PubMed ID: 21051839
    [No Abstract]   [Full Text] [Related]  

  • 39. [New trends in dosage in sulfonamide therapy of obstetrical and gynecological infections].
    Goisis M; Curcio L
    Minerva Ginecol; 1966 Sep; 18(18):1036-42. PubMed ID: 5992547
    [No Abstract]   [Full Text] [Related]  

  • 40. [Penetracyne in gynecology and obstetrics].
    Nelken S; Theoleyre J; Thoulon JM; Grobert ; Dumont P
    Rev Bras Med; 1965 May; 22(5):310-2. PubMed ID: 4953990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.